|
What is Deep Vein Thrombosis (DVT)?
Deep vein thrombosis (DVT) occurs when a blood clot,
or thrombus, develops in the large veins of the legs,
pelvic area, or arms. Only half of those with DVT will
have typical symptoms of leg or arm swelling and pain.
In rare cases, DVT may also occur in the veins of the
arms. With prompt diagnosis and treatment, the majority
of DVTs are not life-threatening. However, if the blood
clot breaks loose and travels through the heart to the
lung, a condition known as a pulmonary embolism (PE)
occurs. If the traveling clot, called an embolus, clogs the
main lung artery, it can be fatal. On average, an estimated
650,000 PEs occur annually, placing it as the third most
common cause of hospital death.
More people suffer from DVT annually than from heart
attack or stroke. Each year up to two million Americans
are affected by DVT and up to 600,000 are hospitalized.
DVT affects men and women, all ethnic groups and all
social levels. It is seen most often in adults over the age
of 40, and more frequently in elderly patients, but can
occur at any age. Women in the later stages of pregnancy
or for 4-6 weeks after delivery are at increased risk.
Other conditions may also increase one's risk, and individuals
who smoke or are immobile are at increased risk.
How Is DVT Diagnosed?
The most commonly used method for diagnosing DVT
is by an ultrasound exam. This simple, painless test is
safe and widely available. A specific blood test may also
be performed to measure "D-dimer," which is a sign of
recent clotting. When this test is negative, it is unlikely
that DVT has occurred.
What Are the Causes of DVT?
DVT is generally caused by a combination of two or
three underlying conditions:
- slow or sluggish blood flow through a deep vein
- a tendency for a person's blood to clot quickly (also called a hypercoagulable state or thrombophilia)
- irritation, inflammation, or injury to the inner lining of the vein
There are a variety of settings in which this abnormal
clotting process can occur. These include individuals on
bed rest (such as during or after a surgical procedure or
prolonged medical illness, such as heart attack or stroke)
or those who are confined and unable to walk for prolonged
periods of time (such as the confining environment
of air or car travel). It can also occur in certain families
with a history of parents or siblings who have suffered
from prior blood clots. It has been found to occur
in individuals who have active cancer or are undergoing
cancer treatment, which may predispose the blood to
clotting. A recent major surgical procedure, especially hip
and knee orthopedic surgeries, or any treatment that
requires prolonged bed rest, also predisposes the blood to
clotting. Additionally, irritation or inflammation occurs
when a leg vein is injured by a major accident, surgical
procedure or invasive medical procedure.
Also, there are specific medical conditions and other
factors that may increase your risk of developing a DVT
via these three mechanisms, such as congestive heart failure,
severe obesity, chronic respiratory failure, a history of
smoking, varicose veins, pregnancy, and estrogen treatment
in the form of birth control pills or hormone
replacement therapy. If you are concerned that you may
be at risk due to any of these conditions, you are encouraged
to consult with your physician.
Treatment:
Both DVT and PE are treated with blood-thinning
medication. These medicines, called anticoagulants,
decrease your blood's ability to clot and can also stop
clots from getting bigger. The use of medication may also
prevent new clots from forming. They do not, however,
break up existing clots that have already formed. The
body's natural systems will help dissolve the clot to varying
degrees. The length of time the patient is treated with
anticoagulants depends on a number of factors, and is
determined by a physician.
Some doctors may recommend sequential compression
devices to promote blood flow after surgery-particularly
orthopedic surgery such as hip or knee replacement.
Anticoagulant therapy prevents further clots from forming
and diminishes the risk of a pulmonary embolus. It consists of heparin, which may be given intravenously or,
more frequently, by subcutaneous injection. A newer
subcutaneous injection medication can also be used to
treat blood clots. Warfarin (Coumadin®), which can be
given orally, is continued on an outpatient basis.
The physician may also recommend thrombolysis,
using an intravenous agent that dissolves blood clots.
This medication is given by a catheter that is threaded up
through the vein to the clot, and one of the clot-dissolving
drugs is injected to dissolve it. The clotbuster is
injected slowly through a catheter (which has many tiny
holes) into the area of the DVT, much like a soaker hose.
Sometimes a tiny vacuum cleaner type of device is used
to suck out the softened clot. Once the clot is gone, balloon
angioplasty or stenting may sometimes be necessary
to open the narrowed vein, but this is common only in
the larger veins, located in the leg or pelvic area. With
this approach, the patient will also need anticoagulants
to prevent new blood clot formation while the existing
clot is being dissolved.
For some patients, extraction of the clot
(thrombectomy), through a small incision at the groin,
may be recommended. These approaches are designed to
remove the clot and restore the venous system to normal,
but they involve additional risk and expense and therefore
are applied selectively by the appropriate vascular
specialist. Clot removal, by either technique, is usually
recommended only for major clots higher up in the leg,
and particularly in active, healthy patients without any
serious associated diseases. It can significantly reduce the
serious late after-effects of DVT in the legs, such as
chronic leg swelling, discoloration and, ultimately, ankle
ulcers, but it does so at an increased risk of serious
bleeding.
Current recommendations are that all patients with leg
DVT wear a prescription support stocking to help
decrease the risk or treat symptoms of leg swelling. The
stockings also help to prevent the skin changes that can
occur over time (as mentioned above) including skin irritation,
skin discoloration, scarring, and leg ulcers. This
condition is called post-thrombotic syndrome.
Can DVT Be Prevented?
Persons who undergo major surgery are at risk to
develop DVT; therefore, exercising the calf and leg before
surgery and resuming physical activity as soon as possible
after surgery will decrease the risk for DVT.
Preventing DVT is the major reason why hospitals have
patients up and walking as soon as possible after surgery.
Regular stretching and leg movement are important for individuals who sit at a desk all day or are traveling in a
confined space on long trips, such as in air travel. Other
recommendations are to refrain from smoking cigarettes
and to maintain a normal body weight. If you are in the
hospital for any reason and have any of the risk factors
mentioned above, you should discuss prevention of clots
with your physician.
Sometimes patients cannot take blood thinners or have
recurrent clots on blood thinners. These patients may have
a vena cava filter placed in the major vein in the abdomen
(which drains blood from the legs). This is a device which
stops clots from traveling to the lungs.
| Some Tips to Avoid DVT |
- Do not sit for long periods of time.
- Elevate legs if you are sitting for moderate periods of time.
- If you are on an airplane for more than six hours, get up and walk in the aisles, pump your feet up and down.
- If you are flying, drink plenty of non-alcoholic beverages.
- Keep hydrated. Drink six glasses of water per day.
- Talk to your doctor about the need for medications for long airplane flights.
- If you have varicose veins, wear support hose (especially if pregnant).
- Do not wear constricting garments on the legs (elastic bands or garters).
- Do not smoke.
- Maintain a normal body weight.
- If you have trauma or major surgery, discuss with your doctor the measures taken to reduce the risks of clots.
|
|
About the Author: Robert B. McLafferty, MD
Dr. McLafferty is the Professor of Surgery for Southern
Illinois University School of Medicine, Division of
Vascular Surgery. He is a well-known expert and national
speaker at numerous conferences and other events on
venous diseases.
|